Literature DB >> 34291525

Genetic counseling, virtual visits, and equity in the era of COVID-19 and beyond.

Wendy R Uhlmann1,2,3, Andrew J McKeon2, Catharine Wang4.   

Abstract

Overnight, as a result of the COVID-19 pandemic, telehealth rapidly transitioned from limited application to widespread implementation. The field of genetic counseling was well positioned to make this transition to virtual care since there is generally less of a need for patients to be seen in-person for physical exams or urgent care. Going forward, virtual visits will presumably become a mainstay in the provision of genetic services and it is anticipated that clinics will adopt "hybrid" models with both in-person and virtual visit options. This commentary highlights the successes and challenges in the rapid implementation of virtual visits, focusing on who has benefited versus who has been challenged or left behind. We also discuss genetic testing considerations, including the additional steps required for patients and clinicians when testing is ordered outside of the clinical setting, which can result in delays or a lack of testing altogether. Future research considerations are presented to address the needs among the most vulnerable and help ensure equitable access and benefit.
© 2021 National Society of Genetic Counselors.

Entities:  

Keywords:  COVID-19; disparities; genetic counseling; genetic testing; telegenetics; telehealth; virtual visits

Year:  2021        PMID: 34291525     DOI: 10.1002/jgc4.1469

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  4 in total

1.  Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.

Authors:  Veda N Giri; Rebecca Hartman; Mary Pritzlaff; Carrie Horton; Scott W Keith
Journal:  JCO Precis Oncol       Date:  2022-05

Review 2.  Health equity in the implementation of genomics and precision medicine: A public health imperative.

Authors:  Muin J Khoury; Scott Bowen; W David Dotson; Emily Drzymalla; Ridgely F Green; Robert Goldstein; Katherine Kolor; Leandris C Liburd; Laurence S Sperling; Rebecca Bunnell
Journal:  Genet Med       Date:  2022-04-28       Impact factor: 8.864

3.  Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.

Authors:  Melanie W Hardy; Beth N Peshkin; Esther Rose; Mary Kathleen Ladd; Savannah Binion; Mara Tynan; Colleen M McBride; Karen A Grinzaid; Marc D Schwartz
Journal:  J Community Genet       Date:  2022-04-29

4.  Demographic Barriers for Genetic Testing in High-Risk Breast Cancer Patients in the Northern Michigan Area.

Authors:  Danielle Hebert; Felipe Pacheco; Lisa WintonLi; Asma Taj
Journal:  Cureus       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.